by Steve Michel | Apr 4, 2019 | News, Presentations
Sutro Biopharma to Present at the 18th Annual Needham Healthcare Conference SOUTH SAN FRANCISCO, Calif., April 4, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the 18th Annual Needham Healthcare...
by Steve Michel | Apr 1, 2019 | News, Press Releases
Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments STRO-001 Ongoing Phase 1 Trial in Myeloma and Lymphoma with Initial Safety Data Expected Mid-2019 STRO-002 Phase 1 Clinical Trial Initiated in Ovarian and...
by Steve Michel | Mar 15, 2019 | Press Releases
Sutro Biopharma Initiates Phase I Clinical Trial of STRO-002 for the Treatment of Ovarian and Endometrial Cancers STRO-002, Sutro’s second clinical program, is designed to deliver “toxic payloads” to kill cancer cells Sutro plans to enroll up to 160 patients in...
by Steve Michel | Mar 5, 2019 | Events, Press Releases
Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference SOUTH SAN FRANCISCO, Calif., March 5, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the Cowen and Company...
by Steve Michel | Jan 29, 2019 | Press Releases
Sutro Biopharma Expands Leadership Team with Appointment of Vice President of Chemistry Veteran Pfizer researcher Andreas Maderna, Ph.D., joins the company SOUTH SAN FRANCISCO, Calif., Jan. 29, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced the appointment...
